Array BioPharma Inc. has hired Curtis Oltmans as general counsel, the company announced earlier this week. Oltmans, a pharmaceutical in-house veteran, comes to the company from Novo Nordisk Inc., where he most recently served as corporate vice president and GC for North America.

Based in Boulder, Colorado, Array BioPharma specializes in the discovery, development and commercialization of targeted small-molecule drugs to treat cancer patients.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]